Terms: = Cervical cancer AND TG, Thyroglobulin AND Staging
18 results:
1. Incidental Thyroid Tissue in Sentinel Nodes From Oral Squamous Cell Carcinoma.
Schilling C; Collins L; Farrow A; McGurk M; Bisase B; Kerawala C; Wan S; Hall G; Thavaraj S
Laryngoscope; 2024 Mar; 134(3):1278-1281. PubMed ID: 37610258
[TBL] [Abstract] [Full Text] [Related]
2. Lymphatic Contrast-enhanced US to Improve the Diagnosis of cervical Lymph Node Metastasis from Thyroid cancer.
Zhang Y; Lu YY; Li W; Zhao JH; Zhang Y; He HY; Li J; Luo YK
Radiology; 2023 May; 307(4):e221265. PubMed ID: 37014243
[TBL] [Abstract] [Full Text] [Related]
3. [Prediction and investigation of the potential risk factors for the upper mediastinal metastasis of papillary thyroid carcinoma].
Liu Y; Xu SY; Liu K; Wang XL; Liu SY; Xu ZG; Liu J
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):477-483. PubMed ID: 33902211
[No Abstract] [Full Text] [Related]
4. [ANAPLASTIC TRANSFORMATION OF METASTATIC PAPILLARY THYROID CARCINOMA IN A cervical LYMPH NODE - A TIMELINE].
Horev Y; Vaknine H; Cinamon U
Harefuah; 2020 Nov; 159(11):809-814. PubMed ID: 33210851
[TBL] [Abstract] [Full Text] [Related]
5. Response to Treatment is Highly Predictable in cN0 Patients with Papillary Thyroid Carcinoma.
Gorshtein A; Benbassat C; Robenshtok E; Shimon I; Hirsch D
World J Surg; 2016 Sep; 40(9):2123-30. PubMed ID: 27094559
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence.
Lee J; Song Y; Soh EY
World J Surg; 2014 Apr; 38(4):858-62. PubMed ID: 24305921
[TBL] [Abstract] [Full Text] [Related]
7. Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer.
Wang TS; Evans DB; Fareau GG; Carroll T; Yen TW
Ann Surg Oncol; 2012 Dec; 19(13):4217-22. PubMed ID: 23010732
[TBL] [Abstract] [Full Text] [Related]
8. Usefulness of thyroglobulin measurement in needle washouts of fine-needle aspiration biopsy for the diagnosis of cervical lymph node metastases from papillary thyroid cancer before thyroidectomy.
Kim DW; Jeon SJ; Kim CG
Endocrine; 2012 Oct; 42(2):399-403. PubMed ID: 22350587
[TBL] [Abstract] [Full Text] [Related]
9. Predictive factors related to the recurrence at US-guided fine needle aspiration in postoperative patients with differentiated thyroid cancer.
Hahn SY; Shin JH; Han BK; Ko EY; Kang SS; Chung JH; Kim JH; Oh YL; Son YI
Clin Endocrinol (Oxf); 2011 Feb; 74(2):270-5. PubMed ID: 21044120
[TBL] [Abstract] [Full Text] [Related]
10. Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate.
Bruno R; Giannasio P; Chiarella R; Capula C; Russo D; Filetti S; Costante G
Thyroid; 2009 May; 19(5):531-3. PubMed ID: 19416000
[TBL] [Abstract] [Full Text] [Related]
11. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.
Bonnet S; Hartl D; Leboulleux S; Baudin E; Lumbroso JD; Al Ghuzlan A; Chami L; Schlumberger M; Travagli JP
J Clin Endocrinol Metab; 2009 Apr; 94(4):1162-7. PubMed ID: 19116234
[TBL] [Abstract] [Full Text] [Related]
12. Nodal status in the papillary thyroid vancer. Comparison of the results of routine histopathological examination, immunohistochemistry and reverse transcription - polymerase chain reaction.
Kaczka K; Jakubiak-Wielganowicz M; Zawlik I; Ziolkowski R; Kuzdak K; Pomorski L
Neoplasma; 2008; 55(6):513-8. PubMed ID: 18999880
[TBL] [Abstract] [Full Text] [Related]
13. High rate of persistent/recurrent disease among patients with differentiated thyroid cancer in Saudi Arabia: factors affecting nonremission.
Raef H; Alfadhli E; Al-Hajjaj A; Malabu UH; Al-Sobhi S; Rifai A; Al Nuaim A
Ann Saudi Med; 2008; 28(4):277-81. PubMed ID: 18596397
[TBL] [Abstract] [Full Text] [Related]
14. Detection and surgical treatment of cervical lymph nodes in differentiated thyroid cancer.
Watkinson JC; Franklyn JA; Olliff JF
Thyroid; 2006 Feb; 16(2):187-94. PubMed ID: 16676409
[TBL] [Abstract] [Full Text] [Related]
15. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.
Frilling A; Tecklenborg K; Görges R; Weber F; Clausen M; Broelsch EC
Ann Surg; 2001 Dec; 234(6):804-11. PubMed ID: 11729387
[TBL] [Abstract] [Full Text] [Related]
16. [Current diagnostic method, prognosis estimation and therapy of papillary thyroid cancer: recommendations of the medical universities and the National Oncologic Institute of Budapest].
Esik O; Balázs C; Boér A; Csernay L; Földes J; Füzy M; Horváth OP; Julesz J; Kásler M; Laczi F; Leövey A; Lukács G; Németh G; Perner F; Repa I; Szabolcs I; Szentirmay Z; Trón L; Balázs G
Orv Hetil; 2000 Jan; 141(1):5-16. PubMed ID: 10673852
[TBL] [Abstract] [Full Text] [Related]
17. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract] [Full Text] [Related]
18. Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.
Martins RG; Caplan RH; Lambert PJ; Rooney B; Kisken WA
J Am Coll Surg; 1997 Oct; 185(4):388-97. PubMed ID: 9328388
[TBL] [Abstract] [Full Text] [Related]
